RT Journal
A1 Meyerhoff A, Murphy D
T1 GUidelines for treatment of anthrax
JF JAMA
JO JAMA
YR 2002
FD October 16
VO 288
IS 15
SP 1848
OP 1849
DO 10.1001/jama.288.15.1845
UL http://dx.doi.org/10.1001/jama.288.15.1845
AB 
First, Inglesby et al state that there are no US Food and Drug Administration
(FDA)–approved postexposure antibiotic regimens following exposure to
a Bacillus anthracis aerosol. In fact, on August
30, 2000, the FDA approved ciprofloxacin for use in inhalational anthrax (postexposure)
for both adults and children. (Inhalational anthrax postexposure is also referred
to as anthrax postexposure prophylaxis [PEP].)